A facile way for development of three-dimensional localized drug delivery system for bone tissue engineering.
Removing malignant bone tumors results in critical size bone defects. These voids in bones should be filled by a proper scaffold that not only can support cell ingrowth and bone regeneration but also it has to show a desirable ability in long-term releasing anticancer drugs in order to prevent the growth of remaining cancer cells. Applying this scaffold can significantly improve the outcome of bone tumors treatment. In this study, a novel way is proposed for immobilization of doxorubicin (DOX)-loaded polycaproloactone (PCL) microparticles on the hardystonite (HT) scaffold surfaces. High interconnected porous HT scaffolds with immobilized DOX-encapsulated PCL microparticles can be successfully fabricated by modified water/oil/water method. In the present work, we verify a slow release of DOX over 30 days from PCL microparticles inside HT scaffold. Our developed HT scaffolds with the long-term release of DOX are more effective in reduction of Saos-2 cancer cells viability and induce higher degrees of apoptosis compared to DOX dip coated HT scaffolds. Encapsulating DOX into PCL microparticles significantly improves the anti-tumor activity of DOX by regulating the expression of apoptosis-related genes. Our results suggest that by immobilization of polymeric vehicles on the ceramic scaffold for controlled drug release, we can achieve high efficiency in apoptosis of cancer cells.